Abpro Signs US$1.75 B Collaboration Deal with Celltrion

By Amit Kaushik

Pharma Deals Review: Vol 2022 Issue 10 (Table of Contents)

Published: 14 Oct-2022

DOI: 10.3833/pdr.v2022.i10.2734     ISSN: 1756-7874

Section: Research & Development



In a bid to boost its pipeline, Abpro has announced a collaboration with Celltrion for the co-development and commercialization of bispecific antibody, ABP-102...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details